Is Bonomarlot FDA approved?
No. This profile records Bonomarlot as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE BLOOD BUILDER
A-20 bone marrow peptide bioregulator
Bonomarlot is derived from animal bone marrow and contains peptides that help restore blood cell production. It targets the stem cells in your bone marrow, helping them produce more red blood cells, white blood cells, and platelets. This makes it valuable for immune support, recovery from illness, and anti-aging as blood production naturally declines with age.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Bonomarlot as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 30 mg daily.
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Short peptides bind to bone marrow DNA to restore protein synthesis
Stimulates stem cells to produce red and white blood cells
Increases lymphocyte, neutrophil, and monocyte production
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.